Clinical Trials Browser

Phase 1 × Primary Myelofibrosis × tagraxofusp × Clear all

NCT05233618 2025-05-28

Study of Tagraxofusp for Post-Transplant Maintenance for Patients With CD 123+ AML, MDS, MF and CMML (HSCT 002)

Phase 1 Recruiting

MyeloidOther hematologic neoplasm

Leukemia, Myeloid, Acute, Leukemia, Myelomonocytic, Chronic, Primary Myelofibrosis